A 16-year-old boy with severe gamma-butyrolactone (GBL) withdrawal delirium.
Zepf
F D
FD
Holtmann
M
M
Duketis
E
E
Maier
J
J
Radeloff
D
D
Wagner
A
A
Poustka
F
F
Wöckel
L
L
D015107:4-Butyrolactone / Q000009:adverse effects*; D000293:Adolescent; D002491:Central Nervous System Agents / Q000009:adverse effects*; D003693:Delirium / Q000139:chemically induced*; D006801:Humans; D008297:Male; D013375:Substance Withdrawal Syndrome / Q000628:therapy; D016896:Treatment Outcome
D002491:Central Nervous System Agents; D015107:4-Butyrolactone